GAULT CHERYL (Chief Operating Officer) sold 5.9% of their position (10K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $281.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/31/2026ACC: 0001193125-26-134684
Officer· Chief Operating Officer
Since Mar 2026
-10K
Net shares
Net seller
$281.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.16K
Price / share
$28.04
Trade value
$200.80K
% of position
4.2%
3/30/2026
169.91K→162.75K
Common Stock
Direct
Shares
−2.84K
Price / share
$28.55
Trade value
$81.06K
% of position
1.7%
3/30/2026
162.75K→159.91K
Total
Net shares
−10K
Net value
-$281.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/30/2026 | S · Sale | −7.16K | $28.04 | $200.80K | 4.2% | 169.91K | 162.75K |
| Common Stock Direct | 3/30/2026 | S · Sale | −2.84K | $28.55 | $81.06K | 1.7% | 162.75K | 159.91K |
| Total | −10K | -$281.86K | ||||||
Derivative Transactions0
No derivative transactions reported